Adolfo Figueiras *

Autor invitado por SIIC

REVISIÓN SISTEMÁTICA

FACTORES DETERMINANTES DE LA SUBNOTIFICACIÓN DE REACCIONES ADVERSAS A LOS MEDICAMENTOS

Esta revisión bibliográfica evalúa las influencias de las características personales y profesionales, así como identifica los conocimientos y actitudes relacionadas con la notificación de reacciones adversas a los medicamentos. Mientras que los factores personales y profesionales muestran una débil influencia, los conocimientos y actitudes aparecen fuertemente relacionados.

*Adolfo Figueiras
describe para SIIC los aspectos relevantes de su trabajo
DETERMINANTS OF UNDER-REPORTING OF ADVERSE DRUG REACTIONS
Institución principal de la investigación
*Universidad de Santiago de Compostela, Santiago De Compostela, España
Imprimir nota

Referencias bibliográficas
1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients:a meta-analysis of prospective studies. JAMA 279:1200-1205, 1998.
2. Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJM, Aronson JK, Grahame-Smith DG. Adverse drug reaction in a hospital general medical unit meriting notification to the Committee on Safety of Medicine. Br J Clin Pharmacol 42:423-429, 1996.
3. Ibanez L, Laporte JR, Carne X. Adverse drug reactions leading to hospital admission. Drug Saf 6:450-459, 1991.
4. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 277:307-311, 1997.
5. Edwards I, Olsson S. WHO-global monitoring. In: Mann RD, Andrews E, editors. Pharmaocvigilance. Chichester, John Wiley & Sons, pp. 169-182, 2002.
6. Waller P, Bahri P. Regulatory pharmacovigilance in the EU. In: Mann RD, Andrews E, editors. Pharmacovigilance. Chichester, John Wiley & Sons, pp. 183-194, 2002.
7. Ahmad SR. Adverse drug event monitoring at the Food and Drug Administration. J Gen Intern Med 285:437-443, 2003.
8. Lexchin J. Is there a role for spontaneous reporting of adverse drug reactions? CMAJ 174:191-192, 2006.
9. Wysowsky DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch Intern Med 165:1363-1369, 2005.
10. Hazell L, Shaki S.A. Under-reporting of adverse drug reactions: A systematic review. Drug Saf 29:385-396, 2006.
11. Inman WHW. Assessment of drug safety problems. In: Gent M, Shigmatsu I, eds. Epidemiological issues in reported drug-induced illnesses. Honolulu, Ontario: McMaster University Library Press, pp. 17-24, 1976.
12. Inman WHW, Weber JCT. The United Kingdom. In: Inman WHW, ed. Monitoring for drug safety, 2nd Edition. Lancaster. United Kingdom: MTP pres Ltd., pp. 13-47, 1986.
13. Inman WHW. Attitudes to adverse drug-reaction reporting. Br J Clin Pharmacol 41:433-435, 1996.
14. Van Grootheest K, Olsson S, Couper M, De Jong-Van den Berg L. Pharmacists' role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf 13(7):457-64, 2004.
15. Milstien JB, Faich GA, Hsu JP, Knapp DE, Baum C, Dreis MW. Factors affecting physician reporting of adverse drug reactions. Drug Inf J 20:157-164, 1986.
16. Walker SR, Lumley CE. The attitudes of general practitioners to monitoring and reporting adverse drug reactions. Pharm Med 1:195-203, 1986.
17. Robins AH, Weir M, Biersteker EM. Attitudes to adverse drug reactions and their reporting among medical practitioners. S Afr Med J 72:131-134, 1987.
18. Rogers AS, Israel E, Smith CR, Levine D, McBean AM, Valente C, Faich G. Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Arch Intern Med 148:1596-1600, 1988.
19. Scott HD, Thacher-Renshaw A, Rosenbaum SE, Waters WJ Jr, Green M, Andrews LG, Faich GA. Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project. JAMA 263:1785-1788, 1990.
20. Fincham JE. Hospital and nursing home pharmacists' attitudes toward adverse drug reaction reporting. J Soc Admin Pharm 7:117-122, 1990.
21. Bateman DN, Sanders GL, Rawlins MD. Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol 34:421-426, 1992.
22. Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong. Ann Pharmacother 28:1400-1403, 1994.
23. Gram LF. Attitude and considerations of Danish physicians towards reporting of adverse drug reactions--A questionnaire study under European direction. Ugeskr Laeger 157:1692-1694, 1995.
24. Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood SM. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 39:223-226, 1995.
25. Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother 29:365-359, 1995.
26. Pouget-Zago P, Lapeyre-Mestre M, Bagheri H, Montastruc JL. Attitudinal survey about the drug surveillance system in general practitioners and residents in the south of France. Therapie 50:459-462, 1995.
27. Van Riemsdijk MM, Herings RMC, Rawlins MD, Stricker BHC. Reasons for (not) reporting adverse reactions to drugs to The Netherlands centre for monitoring of adverse reactions to drugs. Ned Tijdschr Geneeskd 139:2306-2308, 1995.
28. McGettigan P, Feely J. Adverse drug reaction reporting: Opinions and attitudes of medical practitioners in Ireland. Pharmacoepidemiol Drug Saf 4:355-358, 1995
29. Wallace SM, Suveges LG, Gesy KF. Adverse drug reaction reporting, part I: Survey of pharmacists and physicians in Saskatchewan. Drug Inf J 29:571-579, 1995.
30. Kurz X, Van Ermen A, Roisin T, Belton KJ. Knowledge and practice of adverse drug reaction reporting by Belgian physician.

Otros artículos de Adolfo Figueiras

Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Saf 36(5):317-28, 2013. doi: 10.1007/s40264-013-0058-2.
Lopez-Gonzalez E, Herdeiro MT, Piñeiro-Lamas M, Figueiras A; GREPHEPI group. Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial. Drug Saf 38(2):189-96, 2015. doi: 10.1007/s40264-014-0256-6.

Para comunicarse con Adolfo Figueiras mencionar a SIIC como referencia:
adolfo.figueiras@usc.es

---

Acerca del trabajo completo

FACTORES DETERMINANTES DE LA SUBNOTIFICACIÓN DE REACCIONES ADVERSAS A LOS MEDICAMENTOS

Título original en castellano
FACTORES DETERMINANTES DE LA INFRANOTIFICACION DE REACCIONES ADVERSAS A MEDICAMENTOS: UNA REVISION SISTEMATICA

Autor
Adolfo Figueiras¹
1 Profesor, Investigador, Universidad de Santiago de Compostela, Santiago De Compostela, España, Catedrático de Salud Pública

Acceso a la fuente original
Drug Safety
http://adisonline.com/drugsafety/Pages/default.aspx

El artículo se relaciona estrictamente con las especialidades de siicsalud
El artículo se conecta secundariamente con las especialidades